Skull base tumors constitute one of the established indications for particle therapy, specifically proton therapy. However, a number of prognostic factors, practical clinical management issues, and the emerging role of carbon ion therapy remain subjects of active clinical investigation. This review summarizes these topics, assesses the present status, and reflects on future research directions focusing on the management of chordomas, one of the most aggressive skull base tumors. In addition, the role of particle therapy for benign tumors of the skull base, including pituitary adenoma and acoustic neuroma, is reviewed.
机构:
Univ Toronto, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, CanadaUniv Toronto, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada
机构:
Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA
Harvard Med Sch, Charlestown, MA USA
Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA
Harvard Med Sch, Charlestown, MA 02129 USAMassachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA
Kritzer, Michael D.
Peterchev, Angel V.
论文数: 0引用数: 0
h-index: 0
机构:
Duke Univ, Dept Psychiat & Behav Sci, Dept Biomed Engn, Dept Elect & Comp Engn,Dept Neurosurg, Durham, NC USAMassachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA
Peterchev, Angel V.
Camprodon, Joan A.
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA
Harvard Med Sch, Charlestown, MA USAMassachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA